Jefferies Reiterates Buy Rating on Humana (HUM)

Jefferies analyst David Windley reiterated a Buy rating and $419.00 price target on Humana (NYSE: HUM).

The analyst commented: "The recent 15% share decline since early Sept is due to fears HUM's ~2.8M PPO contract, H5216, falls from 4.5* to 3.5* and leaves a ~$9 EPS hole in 2026. Some of that negative outcome is priced in, but not all, which sets up a binary event that could see the stock move dramatically in either direction depending on the outcome. However, the math appears in HUM's favor and a 4* result should be the base case which skews risk/reward to the upside, in our view."

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $313.04 yesterday.

You May Also Be Interested In

• Abbott Labs (ABT) PT Lowered to $125 at BTIG
• 3D Systems opens 50,000 sq. ft. facility in Littleton, Colorado
• Santacruz Silver posts Q3 2026 output of 1.5M silver ounces